BioBridgeXAll companies

Inozyme Pharma, Inc.

Pharmaceutical company · Boston, Massachusetts, United States

Inozyme Pharma, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $67 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Inozyme Pharma at a glance

Typepharmaceutical company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2015
SEC industryPharmaceutical Preparations
SEC CIK1693011

What does Inozyme Pharma do?

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $67.4 million sold (2020).

Frequently asked questions about Inozyme Pharma

Where is Inozyme Pharma headquartered?

Inozyme Pharma, Inc. is headquartered in Boston, Massachusetts, United States.

What does Inozyme Pharma do?

Inozyme Pharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

When was Inozyme Pharma founded?

The earliest incorporation on record for Inozyme Pharma, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences